James F. Ewing is a partner and intellectual property lawyer with Foley & Lardner LLP. Dr. Ewing primarily advises pharmaceutical, biotechnology, and nutraceutical clients. In the pharmaceutical and biotechnology sectors, Dr. Ewing works with companies engaged in drug discovery to develop and produce peptide and small molecule therapeutics, encompassing such technologies as computationally assisted drug design, immunology and vaccine technologies, stem cell technologies, neurobiology, drug delivery, gene therapy technologies, nanobiology technologies and biomedical devices. Dr. Ewing is the former vice chair of the firm’s Chemical, Biotechnology & Pharmaceutical Practice and a member of the Life Sciences, Food & Beverage, and Technology Industry Teams.
詹姆斯•尤因博士是美国富理达律师事务所 (Foley & Lardner LLP) 的合伙人及知识产权律师。尤因博士主要为制药，生物技术和保健品行业的客户提供法律咨询。在制药和生物技术领域，他与从事药物开发的公司共同开发和生产多太和小分子疗法，包括以计算辅助的药物设计、免疫学和疫苗技术、干细胞技术、神经生物学、药物输送、基因治疗技术、纳米生物学技术和生物医学设备。同时他之前也是本所化工、生物技术与医药执业组的副主席并且是生命科学、食品和饮料以及新兴技术工业团队的成员。
执业经历
- 为客户提供有关建立和发展专利组合、合作性研究、技术许可、通过风险资本和其他金融交易筹集资金，以及在知识产权权益实施方面的资询
- 为私人及公共融资与并购交易提供尽职调查
- 提供专利无效，自由经营和非侵权的意见书
- 为客户提供有关发起和维护专利抵触程序的咨询
- 为保健品公司在发展天然草药疗法和饮食补充方面提供咨询
专业成就
尤因博士作为一名生物化学家，在学术性的医学院校和药物开发公司拥有15年以上的经验。他著有众多同行审查的科学论文，并应邀对多项科学议题提供意见。尤因博士曾就职于数家马萨诸塞州的药物开发公司，专注于在心血管、生殖、消化道、中枢神经系统治疗以及抗生素等药物的开发。
荣誉
尤因博士因其在知识产权上的杰出工作曾被列入2005-2012年《马萨诸塞州超级律师上升星》(Super Lawyers-Rising Stars®)的特刊中。此外，《LMG生命科学》杂志还在2012年及2015年将尤因博士评选为“生命科学之星”。
教育背景
尤因博士先后毕业于联盟大学Union College（学士学位，优异毕业生称号），奥尔巴尼医学院Albany Medical College（硕士及博士学位），并在萨福克大学法学院Suffolk University Law School获法学博士及优异生称号。
执业资格
尤因博士是马萨诸塞州律师协会的成员，并获准在马萨诸塞州和美国专利商标局执业。
部分法律著作
- “实验开发厕所（LDT）提议：关注美国食药监局（FDA）所提议的针对测试提供者与病患的测试”实验专属先进医疗保健网络，Jolene S. Fernandes, Lisamarie Collins, 以及 James F. Ewing，2016年3月14日
- “实验开发测试（LDTs）-美国食品药品管理局监管的一个新兴领域”推进实验室医疗网络，参与者：Jolene S. Fernandes, James F. Ewing, Lisamarie A. Collins, Jacki Lin以及Linda X. Wu，2015年12月28日。
- “知识的一代，药物发展战略的综合关键因素”, 《马萨诸塞高科技杂志》。作者：James F. Ewing, John M. Garvey和Michel Morency，2004年7月6日
- “专利战略协作为你带来收益”，《马萨诸塞高科技杂志》。作者：Michel Morency, James F. Ewing, Chinh Pham 和 John M. Garvey, 2004年2月2日
- “如何通过专利被许可方帮助您监控侵权者的市场”，《马萨诸塞高科技杂志》。作者：Michel Morency, James F. Ewing和John M. Garvey，2003年10月13日
Representative Experience
- Advising clients on the creation and development of patent portfolios, collaborative research, licensing of technology, raising money through venture capital and other financial transactions, and enforcement of their intellectual property rights.
- Performing due diligence investigations for private and public financings and M&A transactions.
- Providing patent invalidity, freedom to operate and non-infringement opinions.
- Initiating and defending patent interference proceedings for clients.
- Counseling nutraceutical companies engaged in the development of natural herbal remedies and dietary supplements.
Awards and Recognition
Dr. Ewing has been selected for inclusion in the 2005 – 2012 Massachusetts Super Lawyers-Rising Stars® editions for his work in intellectual property. In 2010, the Legal 500 recognized Dr. Ewing for patent prosecution. He was named among the LMG Life Sciences “Life Science Stars” in both 2012 and 2015. Dr. Ewing is a 2016 recipient of Foley & Lardner’s Carl Hitchner Mentor of the Year Award, which is an annual award recognizing outstanding mentoring to young attorneys by partners and senior counsel.
Affiliations
Dr. Ewing is a member of the Massachusetts Bar Association.
Presentations and Publications
- “LDT Proposals: Concerns about the FDA’s proposal LDT regulations on test providers and patients,” Advanced Healthcare Network for Laboratory, Jolene S. Fernandes, Lisamarie Collins, and James F. Ewing, March 14, 2016.
- “Laboratory Developed Tests (LDTs) – An emerging area of FDA regulation,” Advance Healthcare Network for Laboratory, Jolene S. Fernandes, James F. Ewing, Lisamarie A. Collins, Jacki Lin, and Linda X. Wu, December 28, 2015.
- “Knowledge generation, integration key in drug development strategies,” Mass High Tech, James F. Ewing, John M. Garvey, and Michel Morency, July 6, 2004
- “Patent strategy can bring collaboration revenues,” Mass High Tech , Michel Morency, James F. Ewing, Chinh Pham, and John M. Garvey, February 2, 2004
- “How to get licensees to help you monitor the market for infringers,” Mass High Tech, Michel Morency, James F. Ewing, and John M. Garvey, October 13, 2003
Thought Leadership
Dr. Ewing has more than 15 years of experience as a research biochemist in academic medical universities and drug discovery companies. He is the author of numerous peer-reviewed scientific articles and invited reviews on a variety of scientific topics. Dr. Ewing has worked in several Massachusetts-based drug discovery companies with interest in the development of new cardiovascular, reproductive, gastrointestinal and central nervous system therapeutics, as well as antibiotics.